Ananda Developments PLC NHS Medical Cannabis Registry
21 December 2022 - 7:00PM
RNS Non-Regulatory
TIDMANA
Ananda Developments PLC
21 December 2022
21 December 2022
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
NHS MEDICAL CANNABIS REGISTRY
The directors note the recent announcement by the NHS
encouraging the use of its medical cannabis registry and welcomes
this move to increase the awareness, use and potential of cannabis
medicines for UK patients.
https://www.england.nhs.uk/long-read/cannabis-based-products-for-medicinal-use-patient-registry/
-Ends-
ANANDA DEVELOPMENTS PLC +44 (0)7463 686 497
Chief Executive Officer
Melissa Sturgess
Investor Relations
Jeremy Sturgess-Smith
PETERHOUSE CAPITAL LIMITED +44 (0)20 7469 0930
Corporate Finance
Mark Anwyl
Corporate Broking
Lucy Williams
Duncan Vasey
About Ananda Developments
Ananda is an AQSE-listed medical cannabis company creating
UK-based operations to grow and provide carbon zero, consistent,
medical cannabis for the UK and international markets.
The UK medical cannabis market is predicted to be worth GBP450m
by 2025 and the European market is predicted to be worth USD4.2bn
by 2027.
For more information, please visit:
https://anandadevelopments.com/
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAPPGAWPUPPGUU
(END) Dow Jones Newswires
December 21, 2022 03:00 ET (08:00 GMT)
Ananda Developments (AQSE:ANA)
Historical Stock Chart
From Apr 2024 to May 2024
Ananda Developments (AQSE:ANA)
Historical Stock Chart
From May 2023 to May 2024